58. Rayssiguier Y., Guezennec CY. and Durlach J. New experimental and clinical data on the

            relationship between magnesium and sport. Magnes Res 1990, 3(2):93-102.

59. Durlach J., Bac P., Durlach V., Bara M. and Guiet-Bara A. Neurotic, neuromuscular and

            autonomic nervous form of magnesium imbalance. Magnes Res 1997, 10(2):169-95.

62.  Goto Y., Nakamura M., Abe S., Kato M. and Fukui M. Physiological correlates of abnormal

            behaviors in magnesium-deficient rats. Epilepsy Research 1993, 15(2):81-9.

63. Holvey DN. The Merck Manual. 12^th ed. Merck Sharp & Dohme Research Laboratories

            1972, Rahway, N.J. pp. 1091.

64. Ploceniak C. [Bruxism and magnesium, my clinical experiences since 1980]. [Article in

            French]. Rev Stomatol Chir Maxillofac 1990, 91(1):127.

66. Thomas J., Tomb E., Thomas E. and Faure G. Migraine treatment by oral magnesium intake

            and correction of the irritation of buccofacial and cervical muscles as a side effect of

            mandibular imbalance. Magnes Res 1994, 7(2):123-7.

            French]. Rev Stomatol Chir Maxillofac 1990, 91(1):127.

69. Popoviciu L., Asgian B., Delast-Popoviciu D., Alexandrescu A., Petrutiu S. and Bagathal I.

            Clinical, EEG, electromyographic and polysomnographic studies in restless legs syndrome

            caused by magnesium deficiency. Rom J Neurol Psychiatry 1993, 31(1):55-61.

70. Hornyak M., Voderholzer U., Hohagen F., Berger M. and Riemann D. Magnesium therapy

            for periodic leg movements-related insomnia and restless legs syndrome: an open pilot

            study. Sleep 1998, 21(5):501-5.

71. Fantidis P., Ruiz Cacho J., Marin M., Madero Jarabo R., Solera J. and Herrero E. Intracellular

            (polymorphonuclear) magnesium content in patients with bronchial asthma between

            attacks. J R Soc Med 1995, 88(8):441-5.

72. Galland L. Magnesium, stress and neuropsychiatric disorders. Magnes Trace Elem 1991,

            10(2-4):287-301.

73. Goto Y., Nakamura M., Abe S., Kato M. and Fukui M. Physiological correlates of abnormal

            behaviors in magnesium-deficient rats. Epilepsy Research 1993, 15(2):81-9.

74. Burtis CA. and Ashwood ER. Tietz Textbook of Clinical Chemistry. 2^nd edition 1994, W.B.

            Saunders Company: Philadelphia. pp.1953-4.

75. Iakupova LP., Smirnov Alu., Kozlova IA., Gorbachevskaia NL., Kozhushko LF. [Various

            91(8):57-9.

76. Friedlander AH., Cummings JL. Dental treatment of patients with Gilles de la

            Tourette’s Syndrome. Oral Surg Oral Med Oral Pathol 1992, 73(3):299-303.

77. Muller N., Voderholzer U. Kurtz G., Straube A. Tourette’s syndrome associated with

            restless legs syndrome and akathisia in a family. Acta Neurol Scand 1994,

            89(6):429-32.

78. Lin CK., Hsu WY., Wang PJ., Shen YJ. [Gilles de la Tourette syndrome

            associated with epileptiform discharges; report of three cases]. [Chinese].

            Chung Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Tsa Chih 1989, 30(1):61-5.

85. Kozielec T. and Starobrat-Hermelin B. Assessment of magnesium levels in

            children with attention deficit hyperactivity disorder (ADHD). Magnes Res 1997,

            10(2):143-8.

86. Starobrat-Hermelin B. [The effect of deficiency of selected bioelements on

            hyperactivity in children with certain specified mental disorders].

             [Article in Polish]. Ann Acad Med Stetin 1998, 44:297-314.

87. Starobrat-Hermelin B. and Kozielec T. The effects of magnesium physiological

            supplementation on hyperactivity in children with attention deficit disorder

            (ADHD). Positive response to magnesium oral loading test. Magnes Res 1997,

177. Caspi J., Coles JG., Benson LN., Wilson GJ. Brain damage and myocardial

            dysfunction: protectiive effects of magnesium in the newborn pig.

            Ann Thorac Surg 1998, 65(6):1730-6.

178. Micheli F., Lekhumiec E., Magone C. Fernandez Pardal M., Pikielny R., Casas Parera I.

            Treatment of Tourette’s syndrome with calcium antagonists. Clin Neuropharmacol

            1990, 13(1):77-83.

179. Mauskop A., Altura BM. Role of magnesium in the pathogenesis and treatment of

            migraines. Clin Neurosci 1998, 5(1):24-7.

180. Starobrat-Hermelin B. [The effect of deficiency of selected bioelements on

            hyperactivity in children with certain specified mental disorders].

            [Article in Polish]. Ann Acad Med Stetin 1998, 44:297-314.

181. Rimland B. (1988). Controversies in the treatment of autistic children:

             vitamin and drug therapy. [Review]. Journal of Child Neurology. 3:68-72.